Previous 10 | Next 10 |
Novavax, Inc. (NVAX) Baird 2022 Global Healthcare Conference Call September 13, 2022 08:30 ET Company Participants Gregory Glenn - President, R&D John Trizzino - Chief Commercial Officer and Chief Business Officer Presentation Unidentified Analyst ...
Novavax ( NASDAQ: NVAX ) and its partner Serum Institute of India on Tuesday said South Africa's drug regulator had granted full conditional product registration for its COVID-19 vaccine. The conditional nod came from the South African Health Products Regulatory Authority,...
Novavax and Serum Institute of India Announce Full Product Registration in South Africa of Novavax COVID-19 Vaccine as a Primary Series for Adults Aged 18 and Older PR Newswire GAITHERSBURG, Md. , Sept. 13, 2022 /PRNewswire/ -- Novavax, Inc. (Na...
Novavax, Inc. (NVAX) H.C. Wainwright 24th Annual Global Investment Conference September 12, 2022 4:00 PM ET Company Participants Gregory Glenn - Chief Scientific Officer John Trizzino - Chief Business Officer and Chief Commercial Officer Conference Call Partici...
Novavax ( NASDAQ: NVAX ) on Monday said the European Commission had given an expanded approval to its COVID-19 vaccine for use as a booster shot in adults aged 18 years and older. The approval follows a positive recommendation for the protein-based shot to be used ...
Novavax Nuvaxovid™ COVID-19 Vaccine Granted Expanded Conditional Marketing Authorization in the European Union for Use as a Booster for Adults Aged 18 and Older PR Newswire Nuvaxovid™ is now authorized in the EU for use in adults aged 18 and older as a ...
Good news from the Food and Drug Administration (FDA) can send biotech stocks into the stratosphere. And bad news can bring their share prices crashing down. Our Foolish trio is optimistic about Mirati Therapeutics (NASDAQ: MRTX) , Novavax (NASDAQ: NVAX) and Heron Therapeu...
COVID-19 vaccine stocks came under enormous pressure last month. Over the course of August, Moderna 's (NASDAQ: MRNA) shares dipped by a hefty 19.3%, Pfizer 's (NYSE: PFE) stock ticked lower by a notable 10.4%, and Novavax 's (NASDAQ: NVAX) equity lost an eye-catchin...
The economic downturn and the bear market aren't over as inflation and supply chain issues remain big problems for many businesses. Investors are also scaling back the premiums they're willing to pay for stocks. As a result, many high-priced growth stocks have come down in valuation. Th...
Shares of beaten-down biotech Novavax (NASDAQ: NVAX) are under pressure yet again. The vaccine developer's shares were down by 3.3% on average trading volume as of 12:30 p.m. ET Tuesday. For the year, Novavax's stock has now lost a staggering 79% of its value, and on Tuesday...
News, Short Squeeze, Breakout and More Instantly...
2024-05-19 08:49:00 ET Vaccine maker Novavax (NASDAQ: NVAX) isn't dead in the water after all. Though the past 18 months have been tough -- and management warned investors that the business might sink soon -- Novavax reported positive developments in its latest quarterly update that...
Shares of Cracker Barrel Old Country Store, Inc. (NASDAQ:CBRL) fell sharply during Friday's session after the company reduced its dividend and...
2024-05-17 05:40:00 ET Novavax (NASDAQ: NVAX) and Moderna (NASDAQ: MRNA) both entered the coronavirus vaccine race around the same time, in early pandemic days, and their shares soared -- in fact, Novavax rose the most, gaining 2,700% in 2020 compared to a 400% increase for ...